Organon gets FDA approval for expanded TOFIDENCE uses
Go back to Organon gets FDA approval for expanded TOFIDENCE uses| (NYSE: OGN) | Delayed: 13.41 +0.01 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.40 | 52 Week High | $8.00 | |||
| Open | $13.42 | 52 Week Low | $8.00 | |||
| Day High | $13.42 | P/E | N/A | |||
| Day Low | $13.39 | EPS | $0.00 | |||
| Volume | 123,361 | |||||

